Cynata Therapeutics Limited (CYYNF)
USD 0.19
(0.0%)
USD 0.19
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | 1.65 Million | 7.77 Million | 1.54 Million | 7.01 Million | 1.3 Million |
| Cost of Revenue | 280.73 Thousand | 279.96 Thousand | 279.96 Thousand | 279.96 Thousand | 280.73 Thousand | 279.96 Thousand |
| Gross Profit | -280.73 Thousand | 1.37 Million | 7.49 Million | 1.26 Million | 6.73 Million | 1.02 Million |
| Operating Expenses | 12.26 Million | 16.26 Million | 13.83 Million | 9.08 Million | 10.51 Million | 10.06 Million |
| Selling, General and Administrative Expenses | 3.58 Million | 3.86 Million | 4.06 Million | 4.49 Million | 2.93 Million | 3.21 Million |
| Research and Development Expenses | 8.68 Million | 12.39 Million | 8.82 Million | 3.77 Million | 5.91 Million | 5.65 Million |
| Other Expenses | - | 1.91 Million | 8.32 Million | 1.29 Million | 6.73 Million | 1.32 Million |
| Cost and Expenses | 12.54 Million | 16.54 Million | 13.83 Million | 9.08 Million | 10.51 Million | 10.06 Million |
| Operating Income | -12.54 Million | -16.54 Million | -13.83 Million | -9.08 Million | -10.51 Million | -10.06 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -2.31 Million | -1.65 Million | -64.74 Thousand | -92.29 Thousand | -142.35 Thousand | -260.55 Thousand |
| Earnings before Tax | -12.06 Million | -15.93 Million | -5.44 Million | -7.68 Million | -3.63 Million | -8.47 Million |
| Net Income | -9.74 Million | -14.27 Million | -5.44 Million | -7.68 Million | -3.63 Million | -8.47 Million |
| Earnings Per Share Basic | -0.05 | -0.10 | -0.04 | -0.06 | -0.03 | -0.08 |
| Earnings Per Share Diluted | -0.05 | -0.10 | -0.04 | -0.06 | -0.03 | -0.08 |
| Weighted Average Shares Outstanding | 179.63 Million | 145.09 Million | 143.27 Million | 130.42 Million | 104.82 Million | 100.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 179.63 Million | 145.09 Million | 143.27 Million | 130.42 Million | 104.82 Million | 100.21 Million |
| Gross Margin | - | 0.83 | 0.96 | 0.82 | 0.96 | 0.79 |
| EBIT Margin | - | -9.83 | -1.74 | -5.69 | -1.46 | -7.47 |
| Profit Margin | - | -8.63 | -0.70 | -4.97 | -0.52 | -6.47 |
| EBITDA | -12.26 Million | -16.26 Million | -13.55 Million | -8.8 Million | -10.23 Million | -9.78 Million |
| Earnings Before Tax Margin | - | -10.00 | -1.78 | -5.87 | -1.50 | -7.69 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.27 Million | 1.27 Million | -73.34 Thousand | 1.65 Million |
| Cost of Revenue | 140.36 Thousand | 280.73 Thousand | 140.36 Thousand | - | 139.98 Thousand | 279.96 Thousand |
| Gross Profit | -140.36 Thousand | -280.73 Thousand | 1.13 Million | 1.27 Million | -213.32 Thousand | 1.37 Million |
| Operating Expenses | 5.25 Million | 12.26 Million | 6.94 Million | 3.54 Million | 9.17 Million | 16.26 Million |
| Selling, General and Administrative Expenses | 1.58 Million | - | 6.94 Million | 3.02 Million | 9.17 Million | - |
| Research and Development Expenses | 3.66 Million | - | - | - | 6.33 Million | - |
| Other Expenses | - | - | - | - | - | 1.91 Million |
| Cost and Expenses | 5.39 Million | 12.54 Million | 7.08 Million | 3.54 Million | 9.31 Million | 16.54 Million |
| Operating Income | -5.39 Million | -12.54 Million | -7.08 Million | -2.27 Million | -9.31 Million | -16.54 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 4.00 | -2.31 Million | -2.31 Million | - | -2.00 | -1.65 Million |
| Earnings before Tax | -5.2 Million | -12.06 Million | -6.85 Million | -2.27 Million | -9.1 Million | -15.93 Million |
| Net Income | -5.2 Million | -9.74 Million | -4.54 Million | -2.27 Million | -9.1 Million | -14.27 Million |
| Earnings Per Share Basic | -0.03 | - | -0.03 | -0.01 | -0.06 | - |
| Earnings Per Share Diluted | -0.03 | - | -0.03 | -0.01 | -0.06 | - |
| Weighted Average Shares Outstanding | 179.63 Million | 179.63 Million | 179.63 Million | 179.49 Million | 146.14 Million | 145.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 179.63 Million | 179.63 Million | 179.63 Million | 179.49 Million | 146.14 Million | 145.09 Million |
| Gross Margin | - | - | 0.89 | 1.00 | 2.91 | 0.83 |
| EBIT Margin | - | - | -5.46 | -1.73 | 125.03 | - |
| Profit Margin | - | - | -3.57 | -1.78 | 124.13 | -8.63 |
| EBITDA | -5.25 Million | - | -6.94 Million | -2.2 Million | -9.17 Million | - |
| Earnings Before Tax Margin | - | - | -5.57 | -1.78 | 126.94 | -10.00 |
UAMY
SASOF
1711
ESTER
BZ
9723